Cell and gene therapies are revolutionising healthcare and delivering outstanding outcomes for patients. The pipeline of products is growing, providing potential cures for previously intractable conditions and creating new business models for healthcare innovation companies.
The challenges in the production and manufacturing of these new therapies is a recognised bottleneck. Transformation of supply chains and the development of new therapeutic delivery systems will be required to embrace the economic and health opportunities that cell and gene therapies provide.
This event will explore Victoria’s manufacturing capabilities, clinical preparedness and infrastructure requirements to ensure Victoria is “cellular therapy ready”.
Date: Thursday 28th of June 2018
Time: 7:20am – Registration , 7:30am – Networking Breakfast, 8:00am – 9:00am – Presentation and Panel Discussion
Venue: The Cube, ACMI, Federation Square, Melbourne
Dr Dawn Driscoll, CEO, Cell Therapies Pty Ltd.
Dr Tim Oldham, Executive Leader, Tijan Ventures
Brent McPherson – ANZ National BD Manager, World Courier (Australia) Pty Ltd
Prof. Alan Trounson – CEO and Executive Director, Cartherics